Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mannitol treatment is not effective in therapy of rabies virus infection in mice

L. Dufkova, J. Sirmarova, J. Salat, V. Honig, M. Palus, D. Ruzek, AR. Fooks, KL. Mansfield, N. Tordo, D. Jochmans, J. Neyts, B. Martina, P. Koraka, ADME. Osterhaus, ASKLEPIOS consortium,

. 2019 ; 37 (33) : 4710-4714. [pub] 20171220

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025724
E-zdroje Online Plný text

NLK ProQuest Central od 2002-01-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health & Medicine (ProQuest) od 2002-01-01 do Před 2 měsíci
Family Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Health Management Database (ProQuest) od 2002-01-01 do Před 2 měsíci
Public Health Database (ProQuest) od 2002-01-01 do Před 2 měsíci

Odkazy

PubMed 29274698
DOI 10.1016/j.vaccine.2017.12.028
Knihovny.cz E-zdroje

Rabies is a deadly viral disease with an extremely high fatality rate in humans. Previously, it was suggested that an enhancement of the blood-brain barrier (BBB) permeability, which allows immune cells and/or antibodies to enter the central nervous system (CNS) tissue, is critical to clear the infection. In this study, we utilised mannitol to increase BBB permeability in mice infected with highly pathogenic silver-haired bat rabies virus (SHBRV). We found that intraperitoneal injection of mannitol causes a slight, transient increase of BBB permeability in the treated mice. SHBRV-infected mice were treated with intraperitoneally administered mannitol daily from day 3 or day 4 post-infection, but no effect of this treatment on the time of disease onset, clinical signs or survival was observed. This data indicates that the increase of BBB permeability by mannitol is not efficient in promoting CNS virus clearance in SHBRV-infected mice.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025724
003      
CZ-PrNML
005      
20230815111735.0
007      
ta
008      
201125s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.vaccine.2017.12.028 $2 doi
035    __
$a (PubMed)29274698
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Dufkova, Lucie $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
245    10
$a Mannitol treatment is not effective in therapy of rabies virus infection in mice / $c L. Dufkova, J. Sirmarova, J. Salat, V. Honig, M. Palus, D. Ruzek, AR. Fooks, KL. Mansfield, N. Tordo, D. Jochmans, J. Neyts, B. Martina, P. Koraka, ADME. Osterhaus, ASKLEPIOS consortium,
520    9_
$a Rabies is a deadly viral disease with an extremely high fatality rate in humans. Previously, it was suggested that an enhancement of the blood-brain barrier (BBB) permeability, which allows immune cells and/or antibodies to enter the central nervous system (CNS) tissue, is critical to clear the infection. In this study, we utilised mannitol to increase BBB permeability in mice infected with highly pathogenic silver-haired bat rabies virus (SHBRV). We found that intraperitoneal injection of mannitol causes a slight, transient increase of BBB permeability in the treated mice. SHBRV-infected mice were treated with intraperitoneally administered mannitol daily from day 3 or day 4 post-infection, but no effect of this treatment on the time of disease onset, clinical signs or survival was observed. This data indicates that the increase of BBB permeability by mannitol is not efficient in promoting CNS virus clearance in SHBRV-infected mice.
650    _2
$a zvířata $7 D000818
650    _2
$a protilátky virové $x metabolismus $7 D000914
650    _2
$a antigeny virové $x metabolismus $7 D000956
650    _2
$a hematoencefalická bariéra $x účinky léků $x metabolismus $7 D001812
650    _2
$a centrální nervový systém $x účinky léků $x metabolismus $7 D002490
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mannitol $x terapeutické užití $7 D008353
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a vzteklina $x farmakoterapie $x virologie $7 D011818
650    _2
$a virus vztekliny $x účinky léků $x patogenita $7 D011820
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sirmarova, Jana $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
700    1_
$a Salat, Jiri $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic.
700    1_
$a Hönig, Václav, $d 1982- $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic. $7 jcu2012681186
700    1_
$a Palus, Martin $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
700    1_
$a Růžek, Daniel, $d 1981- $u Department of Virology, Veterinary Research Institute, Hudcova 70, CZ-62100 Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic. Electronic address: ruzekd@paru.cas.cz. $7 stk2008441707
700    1_
$a Fooks, Anthony R $u Animal and Plant Health Agency (APHA), Woodham Lane, New Haw, Surrey KT15 3NB, UK; Institute of Infection and Global Health, University of Liverpool, 8 West Derby Street, Liverpool L69 7BE, UK.
700    1_
$a Mansfield, Karen L $u Animal and Plant Health Agency (APHA), Woodham Lane, New Haw, Surrey KT15 3NB, UK; Institute of Infection and Global Health, University of Liverpool, 8 West Derby Street, Liverpool L69 7BE, UK.
700    1_
$a Tordo, Noël $u Unit Antiviral Strategies, Institut Pasteur, 25 Rue du Dr Roux, 75724 Paris Cedex 15, France; Institut Pasteur de Guinée, Gamal Abdel Nasser University, Conakry, Guinea.
700    1_
$a Jochmans, Dirk $u Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven (KU Leuven), 3000 Leuven, Belgium.
700    1_
$a Neyts, Johan $u Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven (KU Leuven), 3000 Leuven, Belgium.
700    1_
$a Martina, Byron $u Viroscience Lab, Erasmus Medical Center, P.O. Box 2040, Ee1726, 3000 CA Rotterdam, The Netherlands; Artemis One Health Research Institute, Molengraaffsingel 10, 2629 JD Delft, The Netherlands.
700    1_
$a Koraka, Penelope $u Viroscience Lab, Erasmus Medical Center, P.O. Box 2040, Ee1726, 3000 CA Rotterdam, The Netherlands.
700    1_
$a Osterhaus, Albert D M E $u Viroscience Lab, Erasmus Medical Center, P.O. Box 2040, Ee1726, 3000 CA Rotterdam, The Netherlands.
710    2_
$a ASKLEPIOS consortium
773    0_
$w MED00004631 $t Vaccine $x 1873-2518 $g Roč. 37, č. 33 (2019), s. 4710-4714
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29274698 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20230815111732 $b ABA008
999    __
$a ok $b bmc $g 1599869 $s 1116410
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 37 $c 33 $d 4710-4714 $e 20171220 $i 1873-2518 $m Vaccine $n Vaccine $x MED00004631
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace